Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Assessment of rVWF Pharmacokinetics in Overweight and Obese VWD Patients Using a Population Pharmacokinetic Model

Sarah A Hale, MS, PhD, Alexander Bauer, Giovanni Smania, Sofia Friberg-Hietala, Martin J Wolfsegger, PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-133503

Published: 2020

Journal Articles

Influence of Obesity on Factor IX Expression after Gene Therapy in a Mouse Model of Hemophilia B

Sogué Coulibaly, Markus Weiller, Alexander Bauer, Johannes Lengler, Stefan Romeder-Finger, Alexandra Kopić, Karima Benamara, Paul Monahan, Hanspeter Rottensteiner, Friedrich Scheiflinger, PhD, Marietta Turecek, Werner Hoellriegl, MD

Blood (2017) 130 (Supplement 1): 4878.

https://doi.org/10.1182/blood.V130.Suppl_1.4878.4878

Published: 2017

Journal Articles

Nonclinical Assessment of Bax 604 (FEIBA STAR) - Reduced Volume Reconstitution & Higher Infusion Rate

Gerald Hoebarth, Alexandra Kopic, Martin Wolfsegger, Cstat (RSS), Alexander Bauer, Peter L. Turecek, PhD, Peter Leidenmuehler, Karima Benamara, Werner Hoellriegl, Marietta Turecek

Blood (2016) 128 (22): 2590.

https://doi.org/10.1182/blood.V128.22.2590.2590

Published: 2016

Journal Articles

Efficacy and Safety of Rivaroxaban: An Observationalmulticenter Cohort Study Reporting the Routine Use in Adolescents & Adults with DVT

Manuela Krause, MD, Alexander Bauer, Hartmut Clausnizer, Gili Kenet, MD, Dorothee Kowalski, Verena Limperger, Ann-Kathrin Pilgrimm-Thorp, Daniela Manner, MD, Ulrike Nowak-Göttl, Prof.

Blood (2014) 124 (21): 5083.

https://doi.org/10.1182/blood.V124.21.5083.5083

Published: 2014

Journal Articles

Concomitant Administration Of Activated Prothrombin Complex Concentrate and Recombinant Activated Factor VII At Low Doses Are Efficacious and Safe In Hemophilic Mice

Michael Dockal, PhD, Sabine Knappe, PhD, Peter Leidenmuehler, Christina Piskernik, DVM, Sylvia Tippl, Marlene Resch, DVM, Dagmar Verdino, DVM, Alexander Bauer, Werner Hoellriegl, PhD, Friedrich Scheiflinger, PhD

Blood (2013) 122 (21): 2353.

https://doi.org/10.1182/blood.V122.21.2353.2353

Published: 2013

NARROW

Assessment of rVWF Pharmacokinetics in Overweight and Obese VWD Patients Using a Population Pharmacokinetic Model

Influence of Obesity on Factor IX Expression after Gene Therapy in a Mouse Model of Hemophilia B

Nonclinical Assessment of Bax 604 (FEIBA STAR) - Reduced Volume Reconstitution & Higher Infusion Rate

Efficacy and Safety of Rivaroxaban: An Observationalmulticenter Cohort Study Reporting the Routine Use in Adolescents & Adults with DVT

Concomitant Administration Of Activated Prothrombin Complex Concentrate and Recombinant Activated Factor VII At Low Doses Are Efficacious and Safe In Hemophilic Mice

Email alerts

ASH Publications

American Society of Hematology

Assessment of rVWF Pharmacokinetics in Overweight and Obese VWD Patients Using a Population Pharmacokinetic Model

Influence of Obesity on Factor IX Expression after Gene Therapy in a Mouse Model of Hemophilia B

Nonclinical Assessment of Bax 604 (FEIBA STAR) - Reduced Volume Reconstitution & Higher Infusion Rate

Efficacy and Safety of Rivaroxaban: An Observationalmulticenter Cohort Study Reporting the Routine Use in Adolescents & Adults with DVT

Concomitant Administration Of Activated Prothrombin Complex Concentrate and Recombinant Activated Factor VII At Low Doses Are Efficacious and Safe In Hemophilic Mice

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only